Role of angiotensin II in experimental membranous nephropathy

F B Gabbai1, C B Wilson, R C Blantz

  • 1Veterans Administration Medical Center, La Jolla, California.

Insights

Angiotensin II (ANG II) does not cause reduced glomerular ultrafiltration coefficient (LpA) in passive Heymann nephritis (PHN). This study indicates ANG II-independent mechanisms are responsible for hemodynamic changes in this model of kidney injury.

Area of Science:

  • Nephrology
  • Renal Physiology
  • Experimental Medicine

Background:

  • Proteinuria in passive Heymann nephritis (PHN) correlates with altered glomerular ultrafiltration coefficient (LpA).
  • Angiotensin II (ANG II) is implicated in glomerular hemodynamic changes in other kidney injury models.

Purpose of the Study:

  • To investigate the role of ANG II in the reduction of LpA during experimental membranous nephropathy (PHN).

Main Methods:

  • Rats with PHN were treated with a converting enzyme inhibitor (CEI) either acutely or chronically.
  • Measurements included mean arterial pressure (MAP), single-nephron glomerular filtration rate (SNGFR), absolute proximal reabsorption (APR), and glomerular capillary hydrostatic pressure (PG).

Main Results:

  • Acute CEI administration lowered MAP, SNGFR, APR, and PG but did not alter LpA.
  • Chronic CEI treatment decreased MAP but increased SNGFR and APR, with unchanged PG and persistently depressed LpA.

Conclusions:

  • The reduction in LpA observed in PHN is independent of Angiotensin II.
  • Other mechanisms, not involving ANG II, mediate the observed changes in glomerular hemodynamics in this model of membranous nephropathy.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...